Dr. Reddy's Laboratories Shows Resilience Amid Mixed Performance Trends in Pharmaceuticals Sector

Dr. Reddy's Laboratories, a prominent player in the Pharmaceuticals & Drugs industry, has shown notable activity today, maintaining performance in line with the sector. The stock has experienced a positive trend over the past six days, accumulating a total return of 7.74% during this period. Today, it opened at Rs 1,179.95 and has consistently traded at this price point.
In terms of moving averages, Dr. Reddy's stock is currently above its 5-day, 20-day, and 50-day averages, although it remains below the 100-day and 200-day moving averages. The company's market capitalization stands at Rs 97,597.90 crore, categorizing it as a large-cap stock. The price-to-earnings (P/E) ratio is recorded at 18.29, significantly lower than the industry average of 35.55.

Over the past year, Dr. Reddy's Laboratories has seen a decline of 2.78%, contrasting with the Sensex's performance of 7.74%. In the short term, the stock has faced challenges, with a year-to-date performance down by 15.75%. However, it has shown resilience over longer periods, with a 3-year performance of 39.50% and a 5-year performance of 44.14%.